Cargando…
Bergenin as a Novel Urate-Lowering Therapeutic Strategy for Hyperuricemia
Bergenin is a C-glucoside of 4-O-methyl gallic acid isolated from several medicinal plants and has multiple biological activities. The aim of this study was to assess the potential usefulness of bergenin in hyperuricemia. We found that bergenin reduced serum urate levels in hyperuricemia mice by pro...
Autores principales: | Chen, Mo, Ye, Chenyi, Zhu, Jianing, Zhang, Peiyu, Jiang, Yujie, Lu, Xiaoyong, Wu, Huaxiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403512/ https://www.ncbi.nlm.nih.gov/pubmed/32850823 http://dx.doi.org/10.3389/fcell.2020.00703 |
Ejemplares similares
-
Physiology of Hyperuricemia and Urate-Lowering Treatments
por: Benn, Caroline L., et al.
Publicado: (2018) -
Bergenin Activates SIRT1 as a Novel Therapeutic Agent for Osteogenesis of Bone Mesenchymal Stem Cells
por: Hou, Weiduo, et al.
Publicado: (2019) -
Trends in the Contribution of Genetic Susceptibility Loci to Hyperuricemia and Gout and Associated Novel Mechanisms
por: Zhao, Jianan, et al.
Publicado: (2022) -
Thyroid Hormone-Regulated Expression of Period2 Promotes Liver Urate Production
por: Chen, Xiaoting, et al.
Publicado: (2021) -
Novel Long Non-coding RNA Expression Profile of Peripheral Blood Mononuclear Cells Reveals Potential Biomarkers and Regulatory Mechanisms in Systemic Lupus Erythematosus
por: Cheng, Qi, et al.
Publicado: (2021)